Meeting of the Parliament (Hybrid) 03 December 2020
I completely understand Mr Ruskell’s question and what prompted it. The JCVI looked very carefully at all the evidence and data that is available from across the UK on the impact of the virus on the BAME community, and it concluded that although people’s background was relevant, age was more relevant to the impact of the virus on the whole community, including the BAME community. In following the JCVI guidance, we must obviously take that into account.
However, our chief medical officer, along with colleagues, continues to consider where we might add in flexibility to our delivery. At this point, I cannot confirm one way or the other whether we will be able to do that. It is extremely important that we follow clinical advice in everything that we do and ensure that access to the vaccine is in proper order of priority and is equitable. However, if that position changes in any respect at all, I will be happy to make sure that members are updated.